New in Antibodies

Download Presentation: Exploiting the modularity of domain antibodies to advance biotherapeutic platforms

21 May 2013 / By megan / Antibodies / 0 comments

Developing therapeutic monoclonal antibodies and ADC’s is a key focus of the pharmaceutical industry’s R&D. The European Antibody Congress 2012 bought together senior level executives [...]

 

More in Antibodies

• 

  Download Presentation: A pipeline of immunoregulatory therapeutic antibodies

  14 May 2013 / By megan / Antibodies / 0 comments

   
• 

  Download Presentation: How the rise of biosimilars will affect antibody development

  10 May 2013 / By megan / Antibodies / 0 comments

   
• 

  Infographic: Alzheimer’s Drug Development in 2013

  9 May 2013 / By Tim / Antibodies, Clinical Trials, Drug Discovery, Featured on app / 3 comments

   
• 

  Increasing struggles in cell therapies manufacturing as production ramps up

  9 May 2013 / By andre / Antibodies, Cell Culture, Clinical Trials, Manufacturing, Regenerative Medicine, Supply Chain & Manufacturing / 0 comments

   
• 

  Biosimilar developers due to cash in on these 5 therapeutic mAbs

  7 May 2013 / By megan / Antibodies, Biosimilars, Drug Discovery / 0 comments

   
• 

  Presentation: Human primary B lymphocytes for the rapid high throughput discovery of native therapeutic monoclonal antibodies

  7 May 2013 / By megan / Antibodies / 0 comments

   
• 

  Download Presentation: Antibody structure-guided optimization: OptimAbs

  30 April 2013 / By megan / Antibodies / 1 comment

   
• 

  Kymab and Novo Nordisk reach mouse-based antibody technology licensing deal

  30 April 2013 / By Tim / Antibodies, Featured on app, Partnering & Investment / 0 comments

   
• 

  Drawn to Science: the glycosylation of antibodies

  29 April 2013 / By Tim / Antibodies, Featured Videos, Featured on app / 0 comments

   
• 

  Download: Interview with Amgen- Opportunities, challenges and strategies for the Asia antibody industry

  26 April 2013 / By jolene / Antibodies / 1 comment